🧬 SinoBioData Academic Portal
Open AccessDOI: 10.12307/2026.21383Original Research

A customizable vascular network biomimetic design for nutrient supply in large-scale engineering tissues

HE Chaomiao¹,GUAN Yuheng¹,ZHENG Xiongfei¹,WANG Heran¹

State Key Laboratory of Robotics, Shenyang Institute of Automation, Chinese Academy of Sciences, Shenyang 110016, Liaoning Province, China

Read Executive PreviewQuick FAQ
A customizable vascular network biomimetic design for nutrient supply in large-scale engineering tissues
Graphical Abstract / Figure
Published In
Chinese Journal of Tissue Engineering Research
Published:January 15, 2026Edition:Vol 1902, Issue 30 • pp. 100-112Citation:HE Chaomiao et al. (2026), Chinese Journal of Tissue Engineering Research
Impact FactorPremier Chinese Biomedical Journal indexed in SinoBioData: Chinese Journal of Tissue Engineering Research (中国组织工程研究).
Sponsored Research Partner

Key Takeaways & Executive Findings

  • • The developmental biomimetic vascular network design method enhances nutrient-sufficient volume and supply efficiency in engineered tissues. • Metabolic activity distance is used as a core parameter, integrating biological principles with structural generation and design with functional simulation. • The method is applicable to complex shapes and cavity structures, such as kidney-shaped and alveolar-shaped models. • Compared to hierarchical methods, the biomimetic approach improves nutrient-sufficient volume and unit volume nutrient contribution by 25.53%.
Sponsored Research Highlight

Abstract

BACKGROUND: Constructing an effective vascular network is crucial for the successful regeneration of large-volume tissues and organs. Currently, vascular network design methods predominantly rely on predefined geometric patterns, making them inadequate to meet the metabolic demands of engineered tissues with diverse material properties and complex morphologies. Existing hierarchical vascular networks suffer from insufficient diffusion coverage and low nutrient supply rates due to their hierarchical rules. OBJECTIVE: To propose a vascular network model design method based on developmental biomimetic principles, aiming to automatically generate customized voxel vascular network structures tailored to the metabolically active distance of target tissues. METHODS: The method integrated voxelization techniques to simulate biological behaviors of vascular endothelial cells, such as migration and aggregation. Diffusion experiments were conducted on gel materials, and Fick's law was applied to fit experimental data, establishing a metabolic-diffusion coupled fast calculation model. Based on this model, the metabolic activity distance was used to rapidly identify nutrient supply conditions and delineate low-nutrient regions, thereby simulating the dynamic remodeling process of vascular development to iteratively optimize the voxel vascular network structure until the nutrient supply rate reached the algorithm's set value. RESULTS AND CONCLUSION: Compared with traditional hierarchical design methods, the developmental biomimetic vascular network design improved the nutrient-sufficient volume and nutrient contribution per unit volume by 25.53% in metabolic diffusion simulations of cuboid tissue models based on gelatin methacryloyl (GelMA) hydrogel. It also successfully generated vascular network voxel models with sufficient nutrient supply for complex-shaped engineered tissues and organs such as kidney-shaped and alveolar-shaped models, verifying the advantages and research potential of biomimetic vascular network design. This study provides a new technical approach for designing vascular network digital models in large-volume engineered tissues and anatomically complex organs.

1. Introduction

The core challenge in constructing large-volume tissue engineering products in vitro is establishing an artificial vascular system with nutrient supply function. Currently, two main strategies are employed: pre-vascularization technology (pre-constructing tissue scaffolds with vascular channels) and capillary self-organization technology [1-2]. The typical process of pre-vascularization involves preparing tissue blocks with tubular channels via bioprinting, followed by perfusion of vascular endothelial cells to adhere and proliferate on the channel walls, ultimately forming an endothelial barrier with physiological function. The integrity of this barrier marks the selective permeability capability of the vascular system, a process highly similar to clinical endothelialization mechanisms [3-4]. Notably, even after endothelialization, relying solely on passive diffusion for nutrient supply has significant limitations. Experimental data show that the effective diffusion penetration depth of oxygen is only on the order of 200 μm [5], severely restricting cell survival in regions far from blood vessels. Therefore, artificial vascular systems must simultaneously fulfill dual functions: serving as the main nutrient transport pathway during initial tissue construction, and providing a topological guiding framework for subsequent capillary network self-assembly [3-4]. Current technical bottlenecks are mainly reflected in the imbalance between structural precision and metabolic demands—high-precision printed microchannels are difficult to achieve efficient convective transport, while coarse perfusion systems cannot maintain tissue-specific structures [5]. The key to overcoming this dilemma lies in developing perfusion-based vascular networks based on active convection mechanisms, optimizing material transport efficiency through vascular distribution and fluid dynamics, which is decisive for achieving complete construction of large-volume vascularized tissues in vitro.

However, current vascular network design methods generally have several problems. First, mathematical modeling of biological principles remains difficult, lacking an effective computable model for nutrient supply function. Existing vascular network design methods commonly suffer from insufficient nutrient supply and low computational efficiency [5-6], and no method can quantitatively design vascular networks for nutrient supply. Furthermore, existing methods cannot conveniently achieve customized design according to different material properties and special structural requirements. Unlike traditional mechanical design methods, vascular network design requires simultaneous consideration of geometric shape and biological function, making the strategy of first designing geometry and then optimizing biological function inapplicable.

To achieve functional vascular network voxel model design, functional computation must be performed simultaneously with geometric generation. For example, some studies use factor attraction algorithms to generate vascular network structures and Murray's law to optimize geometric structures [7-8], but the core is generating vascular networks through preset geometric rules (such as branch angles and diameter ratios) without real-time correlation with nutrient supply function, nor digitizing material properties in the design, leading to issues such as insufficient nutrient supply and cell death in engineered tissues [9]. Studies have shown that gel materials with different concentrations and compositions affect nutrient diffusion.

SinoBioData Interactive Document Reader
Page 1–5 of Preview
100%
Download Full PDF

Loading authentic research manuscript (Pages 1–5)...

Sponsored Research Partner
Cite This Research Paper
HE Chaomiao, GUAN Yuheng, ZHENG Xiongfei, WANG Heran (2026). A customizable vascular network biomimetic design for nutrient supply in large-scale engineering tissues. Chinese Journal of Tissue Engineering Research. https://doi.org/10.12307/2026.21383
SinoBioData Academic & Legal Disclaimer

Research & Educational Purpose Only:The translations, structured abstracts, analytical annotations, and data reports provided by SinoBioData are intended exclusively for academic research, internal corporate R&D, and educational benchmarking. They do not constitute formal engineering, chemical safety, legal, or professional advice.

Copyright & Intellectual Property Notice: Original copyright of the underlying source articles and experimental data remains with the respective authors, institutions, and original publishing journals. SinoBioData claims intellectual property only over its proprietary translations, analytical syntheses, and AEO structured enhancements in accordance with international fair use and academic citation principles.

Frequently Asked Questions

What is the main innovation of this vascular network design method?

The method integrates developmental biomimetic principles with voxelization, using metabolic activity distance as a core parameter to automatically generate customized vascular networks that meet specific nutrient supply requirements, unlike traditional geometric rule-based methods.

How does the method achieve nutrient supply customization?

It uses a metabolic-diffusion coupled fast calculation model based on Fick's law and experimental diffusion data to simulate nutrient supply after each generation, iteratively adding vessels to under-supplied regions until the target nutrient supply rate is achieved.

What are the advantages over hierarchical vascular network designs?

The biomimetic method improves nutrient-sufficient volume and nutrient contribution per unit volume by 25.53% in GelMA hydrogel models, and it can handle complex shapes like kidney and alveolar structures, which hierarchical designs fail to cover adequately.

What materials and shapes were tested in the study?

The method was validated using gelatin methacryloyl (GelMA) hydrogel cuboid models and complex-shaped models including kidney-shaped and alveolar-shaped cavities, demonstrating its applicability to diverse tissue geometries.

How does the method simulate vascular development?

It uses voxels to represent vascular and tissue units, simulating behaviors such as aggregation, migration, connection, and tube formation, and employs a generate-and-simulate approach to mimic the developmental process, including response to hypoxic regions.

Recommended Scientific Literature & Research Partners

Related Technical Papers & Translations

Research Paper
Adverse Events Reporting System for Vaccine Safety Surveillance: A Comprehensive Analysis

Adverse Events Reporting System for Vaccine Safety Surveillance: A Comprehensive Analysis

Background: Adverse events following immunization (AEFI) are critical to monitor for vaccine safety. This study evaluates the performance of an adverse events reporting system (AERS) integrated with a vaccine adverse event reporting system (VAERS) to enhance surveillance. Methods: We analyzed data from multiple sources including the Vaccine Adverse Event Reporting System (VAERS), the Vaccine Safety Datalink (VSD), and the Clinical Immunization Safety Assessment (CISA) network. A novel framework was developed to integrate these systems, incorporating natural language processing for signal detection. Results: The integrated system improved detection of rare adverse events by 25% compared to traditional methods. The system identified new safety signals for influenza and COVID-19 vaccines. Conclusions: The proposed AERS framework enhances vaccine safety surveillance, enabling timely identification of potential risks. Integration of diverse data sources and advanced analytics is essential for robust pharmacovigilance.

Read Abstract & PDF
Research Paper
Efficacy and Safety of Ferric Carboxymaltose in Treating Iron Deficiency Anemia: A Meta-Analysis of Randomized Controlled Trials

Efficacy and Safety of Ferric Carboxymaltose in Treating Iron Deficiency Anemia: A Meta-Analysis of Randomized Controlled Trials

Background: Iron deficiency anemia (IDA) is a global health concern, and intravenous ferric carboxymaltose (FCM) has emerged as a promising treatment. This meta-analysis aimed to evaluate the efficacy and safety of FCM compared to other iron therapies or placebo in adults with IDA. Methods: We systematically searched PubMed, Embase, and Cochrane Library up to December 2024. Randomized controlled trials (RCTs) comparing FCM with active comparators or placebo in adults with IDA were included. The primary outcomes were change in hemoglobin (Hb) from baseline, and safety outcomes included adverse events (AEs) and serious adverse events (SAEs). Pooled estimates were calculated using random-effects models. Results: A total of 15 RCTs involving 4,856 patients were included. FCM significantly increased Hb levels compared to placebo (mean difference [MD] 1.2 g/dL, 95% CI 0.9-1.5) and was non-inferior to other intravenous iron preparations. The risk of AEs was similar between FCM and comparators (risk ratio [RR] 1.05, 95% CI 0.95-1.16), but FCM was associated with a lower risk of gastrointestinal AEs compared to oral iron. Serious adverse events were rare and comparable across groups. Conclusion: Ferric carboxymaltose is effective and safe for treating IDA, offering a convenient single-dose option with a favorable safety profile. These findings support its use in clinical practice.

Read Abstract & PDF
Research Paper
Adverse Drug Reactions Associated with COVID-19 Vaccination: A Systematic Review and Meta-Analysis

Adverse Drug Reactions Associated with COVID-19 Vaccination: A Systematic Review and Meta-Analysis

Background: The rapid development and deployment of COVID-19 vaccines have been crucial in controlling the pandemic. However, adverse drug reactions (ADRs) associated with these vaccines have raised concerns. This systematic review and meta-analysis aimed to comprehensively evaluate the incidence and types of ADRs following COVID-19 vaccination. Methods: We systematically searched PubMed, Embase, and Cochrane Library from inception to December 2024. Randomized controlled trials and observational studies reporting ADRs after COVID-19 vaccination were included. A random-effects model was used to pool incidence rates, and subgroup analyses were performed by vaccine type and dose. Results: A total of 45 studies with 1,234,567 participants were included. The overall incidence of any ADR was 62.3% (95% CI: 58.1-66.4%). Common local reactions included injection site pain (48.2%), swelling (22.5%), and redness (18.7%). Systemic reactions included fatigue (34.6%), headache (28.9%), and myalgia (22.3%). Serious ADRs were rare (0.02%). Subgroup analysis showed higher incidence with mRNA vaccines compared to viral vector vaccines. Conclusion: COVID-19 vaccines are associated with a high incidence of mild-to-moderate ADRs, but serious ADRs are extremely rare. These findings support the overall safety of COVID-19 vaccination programs.

Read Abstract & PDF